These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21849995)

  • 1. GPCRs: Caught in a spectroscopic trap.
    Piehler J
    Nat Chem Biol; 2011 Aug; 7(9):578-9. PubMed ID: 21849995
    [No Abstract]   [Full Text] [Related]  

  • 2. CODA-RET reveals functional selectivity as a result of GPCR heteromerization.
    Urizar E; Yano H; Kolster R; Galés C; Lambert N; Javitch JA
    Nat Chem Biol; 2011 Jul; 7(9):624-30. PubMed ID: 21785426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane.
    Dziedzicka-Wasylewska M; Faron-Górecka A; Andrecka J; Polit A; Kuśmider M; Wasylewski Z
    Biochemistry; 2006 Jul; 45(29):8751-9. PubMed ID: 16846218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor.
    So CH; Varghese G; Curley KJ; Kong MM; Alijaniaram M; Ji X; Nguyen T; O'dowd BF; George SR
    Mol Pharmacol; 2005 Sep; 68(3):568-78. PubMed ID: 15923381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis.
    Dziedzicka-Wasylewska M; Faron-Górecka A; Górecki A; Kuśemider M
    Pharmacol Rep; 2008; 60(5):581-7. PubMed ID: 19066405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers.
    So CH; Verma V; Alijaniaram M; Cheng R; Rashid AJ; O'Dowd BF; George SR
    Mol Pharmacol; 2009 Apr; 75(4):843-54. PubMed ID: 19171671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Fu W; Shen J; Luo X; Zhu W; Cheng J; Yu K; Briggs JM; Jin G; Chen K; Jiang H
    Biophys J; 2007 Sep; 93(5):1431-41. PubMed ID: 17468175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
    Ge H; Zhang Y; Yang Z; Qiang K; Chen C; Sun L; Chen M; Zhang J
    Bioorg Med Chem; 2019 May; 27(10):2100-2111. PubMed ID: 30981605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine/serotonin receptor ligands. Part 17: a cross-target SAR approach: affinities of azecine-styled ligands for 5-HT(2A) versus D1 and D2 receptors.
    Enzensperger C; Görnemann T; Pertz HH; Lehmann J
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3809-13. PubMed ID: 18534847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization.
    Łukasiewicz S; Faron-Górecka A; Dobrucki J; Polit A; Dziedzicka-Wasylewska M
    FEBS J; 2009 Feb; 276(3):760-75. PubMed ID: 19143836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin.
    Free RB; Hazelwood LA; Cabrera DM; Spalding HN; Namkung Y; Rankin ML; Sibley DR
    J Biol Chem; 2007 Jul; 282(29):21285-300. PubMed ID: 17395585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.
    Rashid AJ; So CH; Kong MM; Furtak T; El-Ghundi M; Cheng R; O'Dowd BF; George SR
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):654-9. PubMed ID: 17194762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors: structure and function.
    Strange PG
    Prog Brain Res; 1993; 99():167-79. PubMed ID: 8108547
    [No Abstract]   [Full Text] [Related]  

  • 14. Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation.
    O'Dowd BF; Ji X; Nguyen T; George SR
    Biochem Biophys Res Commun; 2012 Jan; 417(1):23-8. PubMed ID: 22100647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
    Kozell LB; Machida CA; Neve RL; Neve KA
    J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic systems. Dopamine receptors.
    Palermo-Neto J
    Psychiatr Clin North Am; 1997 Dec; 20(4):705-21. PubMed ID: 9443346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor.
    Torvinen M; Kozell LB; Neve KA; Agnati LF; Fuxe K
    J Mol Neurosci; 2004; 24(2):173-80. PubMed ID: 15456930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heterodimeric D1-D2 dopamine receptors: a review].
    Vekshina NL; Anokhin PK; Veretinskaya AG; Shamakina IY
    Biomed Khim; 2017 Jan; 63(1):5-12. PubMed ID: 28251946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor.
    So CH; Verma V; O'Dowd BF; George SR
    Mol Pharmacol; 2007 Aug; 72(2):450-62. PubMed ID: 17519357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.